Wounds, for example, in the treatment of diabetic wounds, the use of the keratinocytes as good biologically active material be combined with the DPP-4 inhibitors
The present invention relates to novel keratinocytes that can be cultured in vitro and their use to prepare products that can be used in the treatment of acute and chronic wounds in combination with DPP-4 inhibitors.本発明は、インビトロで培養し得る新規なケラチン生成細胞、およびDPP-4阻害剤と組み合わせて、急性および慢性の創傷の治療に使用することができる製品を調製するためのその使用に関する。